Publications by authors named "Emma Scull-Brown"

Background: Hypothermia-treated and intubated infants with moderate or severe hypoxic-ischemic encephalopathy (HIE) usually receive morphine for sedation and analgesia (SA) during therapeutic hypothermia (TH) and endotracheal ventilation. Altered drug pharmacokinetics in this population increases the risk of drug accumulation. Opioids are neurotoxic in preterm infants.

View Article and Find Full Text PDF

Background: Therapeutic hypothermia (TH) for 72h is the standard treatment following neonatal encephalopathy (NE). However, one-third do not benefit and adjunctive therapies are urgently needed. Xenon enhances neuroprotection with TH when administered at 50% concentration within 5hours of hypoxia in experimental studies.

View Article and Find Full Text PDF

Background: Opioids like fentanyl are regularly used in neonates for analgesia and sedation. So far, they have been reported to be safe and eligible to use. The cerebellum has become a focus of neurodevelopmental research within the last years, as it is known to play an important role in long-lasting motor, cognitive, and other behavioral changes.

View Article and Find Full Text PDF

Background: We previously reported that combining immediate hypothermia with immediate or 2 h delayed inhalation of an inert gas, xenon, gave additive neuroprotection in rats after a hypoxic-ischemic insult, compared to hypothermia alone. Defining the therapeutic time window for this new combined intervention is crucial in clinical practice when immediate treatment is not always feasible. The aim of this study is to investigate whether combined hypothermia and xenon still provide neuroprotection in rats after a 5 h delay for both hypothermia and xenon.

View Article and Find Full Text PDF

Some psychiatric diseases in children and young adults are thought to originate from adverse exposures during foetal life, including hypoxia and hypoxia/reoxygenation. The mechanism is not understood. Several authors have emphasised that the placenta is likely to play an important role as the key interface between mother and foetus.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the feasibility of using xenon gas alongside therapeutic hypothermia in newborns suffering from moderate to severe neonatal encephalopathy, aiming to enhance neuroprotection.
  • The research included 14 cooled infants, who were given xenon gas in varying doses and monitored for respiratory, cardiovascular, neurological, and inflammatory effects, with results suggesting no serious adverse effects.
  • Follow-up at 18 months indicated promising developmental outcomes for the majority of surviving infants, supporting the viability of xenon as a supplemental treatment during cooling therapy.
View Article and Find Full Text PDF

Background And Purpose: Hypothermia (HT) for neonatal hypoxic-ischemic encephalopathy is advised to start within the first 6 hours after birth. There is some clinical evidence that HT is more effective against moderate than against severe hypoxic-ischemic encephalopathy, but it is unknown whether delayed HT beyond 6 hours is effective or even injurious.

Methods: One-hundred seven 7-day-old rat pups underwent unilateral hypoxia-ischemia of moderate severity.

View Article and Find Full Text PDF